معرفی
Salvatore Ferla is a Senior Lecturer in Pharmacy at Swansea University Medical School, focusing on drug design and synthesis. His research emphasizes in silico methodologies, molecular modeling, and the development of small-molecule therapeutics for cancer, viral, and parasitic diseases. He holds a PhD in Medicinal Chemistry from Cardiff University and leads projects funded by prestigious grants like the SÊR CYMRU Fellowship. Ferla collaborates globally on antiviral strategies and anticancer immunotherapies. His work spans from computational drug discovery to synthetic chemistry, with over 50 peer-reviewed publications. Teaching includes modules like PMP-102 (Drugs & Medicines) and PMP303 (New Knowledge), integrating research into curriculum.
- Education: PhD in Medicinal Chemistry (Cardiff University)
- Research Highlights: Design of norovirus inhibitors, GATA2 leukemia inhibitors, and CYP24A1 inhibitors for cancer.
Research interests include antiviral drugs (e.g., norovirus, EV71), anticancer agents targeting microtubules or immune checkpoints, and molecular modeling. His recent work explores calcilytics for lung disease and epigenetic drug targets in schistosomiasis. Ferla’s articles highlight interdisciplinary approaches blending computational and synthetic chemistry to address global health challenges.
- Awards: SÊR CYMRU Fellowship (2018), WCADD Molecular Modelling Platform co-leadership (2015).
He advises PhD students on topics like GATA2 inhibition in leukemia and norovirus NS1-2 protein targeting. Grants include collaborations across academia and biotech. Ferla contributes to labs focused on drug discovery and precision medicine, emphasizing translational research.
